Replies to post #84520 on Anavex Life Sciences Corp (AVXL)

[falconer66a]

Tom,

Thanks so much.

I know enough about technical analysis only to be dangerous to myself.

But from my naive, inexperienced scan of the price lines, I saw $3.50 as a (for me) favorable buy point target. The 50-day moving average pointed toward that, as far as I could tell.

Likewise, the 200-day moving average, around $4.30 looks to be a higher get-in target, should that hold.

From the Anavex science (for which I know almost as much about as you do TA), I’m certain that in months or a year or two the AVXL shareprice will be solidly in double, perhaps even triple digits. Therefore, whether I wait and luck out around $3.50, or, the trendline ascends and pierces $4.30 and I buy up there, I’ll be rewarded. More shares are better, of course. Would like to make my trade less than $4.00, approaching $3.50.

But if I have to chaise it and grab shares going away at $4.50, so be it. I’ll be happy — even if it retraces after that down to sub-$3.00 for a time. Ain’t gonna stay there, I’m certain. Too many have Alzheimer’s and need a working, workable treatment. The biochemistry of A2-73 provides that (at eventually sharply-ascending AVXL shareprices).

Again, thanks for your detailed discourse.